Viewing Study NCT01478269


Ignite Creation Date: 2025-12-24 @ 11:09 PM
Ignite Modification Date: 2026-02-22 @ 4:53 PM
Study NCT ID: NCT01478269
Status: COMPLETED
Last Update Posted: 2011-11-23
First Post: 2011-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
Sponsor: Fondazione Italiana Linfomi - ETS
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-Cell Lymphomas View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Aggressive B-cell lymphoma View
None R-CHOP View